A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Clinical trial NCT04243785 · RECRUITING
Trial details
- NCT number
- NCT04243785
- Sponsor
- Edgewood Oncology Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-06
- Primary completion
- 2026-03-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.